Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens Accuracy Metrics

Knolens harnesses proprietary AI algorithms to deliver industry-leading extraction precision of >99% and contextual accuracy exceeding 92% across life sciences data. Our platform ensures complete traceability to source documents, enabling confident decision-making with validated, transparent insights.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

What is Knolens KnolScapes?

Unified Intelligence for Strategic Drug Development

Knolscapes is an intelligence platform providing personalized, multi-dimensional analysis across therapeutic landscapes, diseases, and HTA assessments. It offers real-time, configurable analytics that integrate clinical, market, and competitive data to support cross-functional decision-making throughout drug development, saving thousands of hours and reducing costly missteps

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Accelerated intelligence: From siloed processes to synchronized decisions

By eliminating information silos and providing real-time, validated insights to all stakeholders simultaneously, Knolens reduces decision cycles from weeks to days.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Cross-functional intelligence: One platform, multiple perspectives, aligned decisions

Knolens creates a unified intelligence hub where cross-functional teams access the same verified insights, enabling seamless collaboration and aligned decision-making across departments.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Cross Functional

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Economic Burden for Ulcerative Colitis in US and Europe

Knolens aggregates and visualizes direct and indirect cost data across healthcare systems, enabling robust economic models that support your market access strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
HEOR 

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Economic Burden for UC in US and Europe

Knolens provides comprehensive analysis of reimbursement pathways and requirements across major markets. The platform tracks policy changes, submission requirements, and success patterns to optimize market access strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Market Access

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Market intelligence for clinical planning: Target the right patients in the right regions

Knolens' market analysis identifies geographic regions with rising UC prevalence and changing patient demographics, enabling optimized site selection and recruitment strategies for faster, more efficient trial execution

KnolQuest interface showing immunology protocol analysis with biomarker insights

KnolQuest analyzes successful immunology protocols, extracts key design elements, and identifies emerging biomarkers—reducing protocol development time by 80%. Every design decision is supported by traceable evidence, streamlining regulatory submissions and site initiation

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Clinical Development

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

How does Knolens track emerging biomarkers in ulcerative colitis treatment?

Knolens continuously monitors scientific literature and clinical trials to identify emerging biomarkers, enabling targeted scientific engagement with key opinion leaders.

KnolQuest scientific narrative builder for immunology therapy evidence.

KnolQuest extracts relevant scientific evidence across publications, trials, and conference abstracts to build compelling immunology narratives. This comprehensive evidence foundation ensures your scientific communications are accurate, balanced, and aligned with key opinion leader perspectives

Medical Affairs

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Can Knolscapes help identify which competitors are targeting specific biomarkers in immuno-oncology?

Knolscapes biomarker-targeted therapy mapping for advanced esophageal cancer.

Knolscapes maps the biomarker landscape across immuno-oncology competitors, revealing which companies are pursuing similar targets. This intelligence helps you track emerging biomarker trends, identify potential collaborators, and differentiate your biomarker strategy

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Market opportunity intelligence: From epidemiology to strategic investment planning

Knolens integrates global prevalence data, growth projections, and cost analyses to provide comprehensive market sizing, enabling strategic decisions for pipeline prioritization and investment planning

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Comparison of Ulcerative Colitis trials for approved drugs

Knolens provides side-by-side comparison of trial protocols, highlighting key differences in patient populations, endpoints, and outcomes that impact competitive positioning

KnolQuest dashboard showing emerging immunology competitor tracking analysis

KnolQuest continuously monitors scientific publications, clinical trial registries, and conference proceedings to identify emerging immunology competitors before they reach mainstream visibility. This early intelligence helps you anticipate market disruptions and adjust strategy proactively

Competitive Intelligence

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Partnership opportunities in ulcerative colitis landscape

Knolens maps the competitive landscape to reveal strategic gaps, identifying promising assets and potential partners that complement your portfolio strategy.

KnolQuest scientific credibility assessment for immunology partnership candidates

KnolQuest conducts comprehensive scientific assessment of immunology assets, analyzing publication quality, investigator reputation, and underlying data robustness. This evidence-based evaluation helps you identify scientifically sound opportunities and avoid partnerships built on questionable research foundations.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Business Development